ABSI Absci CorporationStock Price & Overview
$1.650.02 (+1.23%)3:15 PM 11/30/23
NASDAQ | $USD | Realtime
People Also Follow
Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington.